Myolex
Brian Kang is a Co-Founder and Managing Director at Nautilus Venture Partners since February 2015. In addition to this role, Brian serves as a Board Observer for DataPelago, Ayar Labs, Ridecell, Rescale, and Cipherome, Inc., and holds Board Member positions at Hiya Inc., Point2 Technology, AIRY3D, and Myolex. Brian Kang's educational background includes an MBA from The University of Texas at Austin, an MS in Mechanical Engineering from the University of Washington, and a BS in Mechanical Engineering from the University at Buffalo.
This person is not in the org chart
This person is not in any teams
Myolex
Myolex is disrupting how to measure muscle wasting (and treatment), caused by obesity drugs, aging, and sport injuries. Myolex® EIM is a patented device technology and SaaS data analytics platform that is built to disrupt skeletal muscle measurement by becoming the clinical and wellness standard to aid in the diagnosis and treatment of obesity drug and age-related muscle wasting. Myolex has developed the 1st quantitative, sensitive, painless, portable for home use muscle quality assessment device that is specifically designed to non-invasively, comprehensibly, and precisely detect and monitor single muscle wasting.